LAST NEWS

ARCHIVE ENTRIES

2018.06.28

Animals in a medical revolution

Wrocław scientists in the comfort of laboratories are preparing drugs that change the standards of treating dogs, cats and horses. Just a little ... More
2018.06.27

Łukasz Bzdzion on the podium!

The Jury of the 8th edition of The 50 Most Creative in Business ranking has decided – Łukasz Bzdzion, Bioceltix CEO, took the second place. The ... More
2018.06.22

The Polish startup creates super modern drugs for animals

As the first company in Europe, Bioceltix intends to authorize a veterinary biopharmaceutical based on stem cells. Łukasz Bzdzion, the CEO of the ... More
2018.06.21

Interview with Łukasz Bzdzion on Impact’18 in Kraków

We was on Impact’18, congress that brings leaders at the forefront of innovation from many sectors together to explore the opportunities ... More
2018.06.21

WallStreet 22 Conference: Łukasz Bzdzion

CEO of Bioceltix, Łukasz Bzdzion, during the WallStreet conference in Karpacz talked about the AlloMSCs technology, biopharmaceuticals based on ... More
2018.06.16

Bioceltix among The 50 Most Creative in Business

Ranking The 50 Most Creative in Business is an initiative that for 7 years has been helping to build and promote the innovative and creative ... More
2018.06.13

The Polish company has created innovative veterinary drugs

– We are the first company in Europe to develop and implement animal-safe and business-scale technology that uses allogeneic stem cells in ... More
2018.06.06

The digital revolution in medicine – an overview of the most interesting Polish technologies

To 2020, the participation of biological medicines in the entire pharmaceutical market will increase to nearly 30%. The veterinary market will ... More